Last reviewed · How we verify

NCT05668559

Transcranial Magnetic Stimulation and Perioperative Neurocognitive Disorders

Status unknown NA Last updated 5 September 2023
What this trial tests

NA trial testing repetitive transcranial magnetic stimulation in Postoperative Cognitive Dysfunction in 280 participants. Status unknown.

Timeline
1 October 2023
Primary endpoint
1 March 2026
1 April 2026

Quick facts

Lead sponsorAnshi Wu
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment280
Start date1 October 2023
Primary completion1 March 2026
Estimated completion1 April 2026

Drugs / interventions tested

Conditions studied

Sponsor

Anshi Wu

Who can join

18 and older, any sex, with Postoperative Cognitive Dysfunction or Repetitive Transcranial Magnetic Stimulation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To investigate the impact of rTMS on the incidence of perioperative neurocognitive disorders in patients after after cardiac surgerysurgery. To explore the underlying mechanisms behind the efficacy.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. The effect of repetitive transcranial magnetic stimulation (rTMS) on perioperative neurocognitive disorders in patients after cardiac surgery: study protocol for a randomized controlled trial.
    Wang J, Wang X, Li S, Yang J, et al · · 2025 · PMID 40707956 · DOI 10.1186/s13063-025-08988-3
  2. The Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) on Perioperative Neurocognitive Disorders in Patients after Cardiac Surgery: Study Protocol for a Randomized Controlled Trial
    Wang J, Wang X, Li S, Yang J, et al · · 2024 · DOI 10.21203/rs.3.rs-3298051/v1

Verify or expand the search:

Other trials of repetitive transcranial magnetic stimulation

Trials testing the same drug.

Other recruiting trials for Postoperative Cognitive Dysfunction

Currently open trials in the same condition.

Other Anshi Wu trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05668559.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing